MedTrace Logo

Safety & Efficacy of Nicotinamide Riboside Supplementation for Improving Physiological Function in Middle-Aged and Older Adults

NCT02921659 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2016-12-01

No results posted yet for this study

Summary

The purpose of this study is to assess the efficacy of supplementation with the Nicotinamide Adenine Dinucleotide (NAD+) precursor compound, Nicotinamide Riboside (NR), for improving physiological function (vascular, motor, and cognitive) in healthy middle-aged and older adults.

Conditions

  • Aging

Interventions

DIETARY_SUPPLEMENT

Niagen™

nicotinamide riboside chloride, 250mg capsules

DIETARY_SUPPLEMENT

Placebo

silicified microcrystalline cellulose, vegetarian capsule

Sponsors & Collaborators

  • ChromaDex, Inc.

    collaborator INDUSTRY

  • University of Colorado, Boulder

    lead OTHER

Principal Investigators

  • Christopher R Martens, Ph.D. · University of Colorado, Boulder

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
55 Years
Max Age
79 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-04-30
Primary Completion
2016-10-31
Completion
2016-10-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02921659 on ClinicalTrials.gov